We are live on ! Find out more
JHC

Jones Hill Capital Portfolio holdings

AUM $470M
This Fund
S&P 500
This Quarter Est. Return
+12.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$466M
AUM Growth
Cap. Flow
+$455M
Cap. Flow %
97.57%
Top 10 Hldgs %
73.06%
Holding
26
New
26
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVBP icon
26
ArriVent BioPharma
AVBP
$1.44B
$1.06M 0.23%
+45,809
New +$1.03M

Similar funds

Jones Hill Capital's Q1 2026 Portfolio in Review

Q1 2026 is the first quarter with a 13F filing on record for Jones Hill Capital, which disclosed 26 positions worth $466M. Its ten largest holdings account for 73% of the portfolio.

Its largest position is BioMarin Pharmaceuticals: 1,268,390 shares worth $71.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Jones Hill Capital's largest Q1 2026 buy was BioMarin Pharmaceuticals: 1,268,390 shares worth $71.7M.
  • Jones Hill Capital's ten largest holdings make up 73% of its $466M portfolio in Q1 2026.
  • Jones Hill Capital disclosed 26 positions in Q1 2026, its first 13F filing on record.

Based on Jones Hill Capital's 13F filing for Q1 2026, filed 14 May 2026.